Deciphera Pharmaceuticals Analyst Ratings
BenzingaApr 29 11:12 ET
Deciphera Pharmaceuticals Acquisition by Ono: A Hold Rating Amidst Prospects and Challenges
TipRanksApr 29 10:25 ET
Piper Sandler Sticks to Their Buy Rating for Deciphera Pharmaceuticals (DCPH)
TipRanksApr 22 08:32 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Deciphera Pharmaceuticals (DCPH) and Shockwave Medical (SWAV)
TipRanksApr 8 08:40 ET
Barclays Keeps Their Sell Rating on Deciphera Pharmaceuticals (DCPH)
TipRanksFeb 21 06:51 ET
Buy Rating Reaffirmed for Deciphera Pharmaceuticals on Strong Q4 Performance and Promising Drug Prospects
TipRanksFeb 7 08:31 ET
Deciphera Pharmaceuticals (DCPH) Gets a Sell From Barclays
TipRanksFeb 7 05:19 ET
Analysts Are Bullish on Top Healthcare Stocks: Deciphera Pharmaceuticals (DCPH), ACADIA Pharmaceuticals (ACAD)
TipRanksFeb 7 00:50 ET
Deciphera Pharmaceuticals: Strong Buy Rating on Robust Financials and Promising Pipeline
TipRanksFeb 6 12:45 ET
Deciphera Pharmaceuticals: Sustained Growth and Market Expansion Drive Buy Rating
TipRanksFeb 6 11:35 ET
Piper Sandler Remains a Buy on Deciphera Pharmaceuticals (DCPH)
TipRanksJan 22 14:23 ET
Stifel Nicolaus Sticks to Their Buy Rating for Deciphera Pharmaceuticals (DCPH)
TipRanksJan 5 07:45 ET
JP Morgan Reinstates Neutral on Deciphera Pharmaceuticals, Announces $14 Price Target
BenzingaNov 20, 2023 08:17 ET
Deciphera Pharmaceuticals Analyst Ratings
BenzingaNov 20, 2023 08:16 ET
Analysts Offer Insights on Healthcare Companies: Deciphera Pharmaceuticals (DCPH) and Ocular Therapeutix (OCUL)
TipRanksNov 6, 2023 00:30 ET
Promising Clinical Trial Results and Financial Performance Lead to Deciphera Pharmaceuticals' Buy Rating Upgrade
TipRanksNov 2, 2023 01:21 ET
Stifel Maintains Buy on Deciphera Pharmaceuticals, Raises Price Target to $22
BenzingaOct 31, 2023 14:00 ET
Deciphera Pharmaceuticals Analyst Ratings
BenzingaOct 31, 2023 13:59 ET
Jones Research Upgrades Deciphera to Buy From Hold
Seeking AlphaOct 31, 2023 13:49 ET
HC Wainwright & Co. Maintains Buy on Deciphera Pharmaceuticals, Raises Price Target to $30
BenzingaOct 31, 2023 07:36 ET
No Data
No Data